IVVD Stock Analysis: Buy, Sell, or Hold?
IVVD - Invivyd, Inc. Common Stock
$0.83
-0.11 (-11.87%)
▼
5d:
-4.86%
30d:
-19.42%
90d:
-35.66%
BUY
HIGH Confidence
Analysis Updated: Jul 8, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When IVVD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called IVVD this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: IVVD shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: IVVD shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: IVVD is currently trading at $0.83, which is considered oversold relative to its 30-day fair value range of $0.84 to $1.05.
Technical Outlook: Technically, IVVD is in a strong downtrend. The price is currently testing key support at $0.81. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 11.9% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+1104.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IVVD is in a strong downtrend. The price is currently testing key support at $0.81. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 11.9% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+1104.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.84 -
$1.05
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-11.9%)
- BULLISH: Trading 1104.8% below Wall St target ($10.00)
Trading Range Analysis
30-Day Trading Range
$0.84 -
$1.05
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.81
Resistance Level
$1.00
Current Trend
Strong Downtrend
Technical data as of
Jul 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.43
Wall Street Target
$10.00
(+1104.8%)
Revenue Growth (YoY)
21.6%
Profit Margin
-138.9%
Share & Embed Analysis
Last updated: July 08, 2026 5:53 PM ET
Data refreshes hourly during market hours. Next update: 6:53 PM
Data refreshes hourly during market hours. Next update: 6:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IVVD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Julie Green
SELL
20964 shares
2026-02-18
Robert D Allen III
SELL
19392 shares
2026-02-18
Timothy Edward Lee
SELL
20964 shares
2026-02-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 61 BUY |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 58 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
